BNP Paribas Financial Markets
BEAM icon

BNP Paribas Financial Markets’s Beam Therapeutics BEAM Stock Holding History

BNP Paribas Financial Markets’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$16.7M Buy
700,647
+231,737
+49% +$6.43M 0.01% 1280
2025
Q4 		$13M Buy
468,910
+444,940
+1,856% +$11.4M 0.01% 1447
2025
Q3 		$582K Sell
23,970
-241,038
-91% -$4.8M ﹤0.01% 3467
2025
Q2 		$4.51M Buy
265,008
+236,207
+820% +$4.11M ﹤0.01% 1926
2025
Q1 		$562K Buy
28,801
+19,249
+202% +$504K ﹤0.01% 3121
2024
Q4 		$237K Buy
+9,552
New +$244K ﹤0.01% 3766

Other funds holding BEAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

BNP Paribas Financial Markets's BEAM Position: Q1 2026 in Review

BNP Paribas Financial Markets increased its Beam Therapeutics (BEAM) stake by 49% in Q1 2026, buying an estimated $6.43M and bringing the position to 700,647 shares worth $16.7M. The position accounts for 0.01% of the portfolio, ranked #1280.

BNP Paribas Financial Markets first reported a position in BEAM in Q4 2024 and has held it in 6 quarters since. 251 funds tracked by Wall St. Rank hold BEAM as of Q1 2026.

  • BNP Paribas Financial Markets held 700,647 shares of Beam Therapeutics worth $16.7M as of Q1 2026.
  • BNP Paribas Financial Markets bought 231,737 Beam Therapeutics shares in Q1 2026, an estimated $6.43M.
  • Beam Therapeutics made up 0.01% of BNP Paribas Financial Markets's portfolio in Q1 2026, its #1280 holding.
  • BNP Paribas Financial Markets first reported a position in Beam Therapeutics in Q4 2024 and has held it in 6 quarters since.
  • 251 funds tracked by Wall St. Rank held Beam Therapeutics as of Q1 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q1 2026, filed 12 May 2026.